While the infant formula segment is driving toward premiumization, fierce competition continues, especially in China, which has accounted for almost half of the global market size. Can probiotics help boost market growth? Explore the opportunities of the well-studied human-residential Bifidobacterium (HRB) strain - Bifidobacterium longum BB536 for use in infant formula.
This Technical Paper is from Morinaga Milk.

READ THIS NEXT: Iron and Celiac Disease

Infant Nutrition
All G and Armor Protéines announce joint venture to commercialize lactoferrin
Australian biotech company All G and French bioactives supplier Armor Protéines have established a joint venture to produce and commercialize human and bovine lactoferrin. Additionally, All G has raised over AU$10 million...

Infant Nutrition
Brazil greenlights Arla Foods Ingredients’ Lacprodan milk fat globule membrane for F&B
Brazilian authorities have approved Arla Foods Ingredients’ Lacprodan MFGM-10 for use in food and beverage products where whey protein concentrate is permitted. Occurring naturally in breast milk, milk fat globule membrane...

Infant Nutrition
Nestlé fires back at accusation of adding sugar to infant cereal in Africa
Nestlé has disputed accusations by the NGO Public Eye that its infant cereals sold in Africa feature added sugar. Recent reports by the NGO claim the Swiss nutritional company’s brands Cerelac and Nestum sold in...
Related multimedia
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement













